Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 34295, 5 pages
http://dx.doi.org/10.1155/MI/2006/34295
Research Communication

Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis

1Department of Gastroenterology, School of Medicine, Firat University, Elazig 23200, Turkey
2Department of Biochemistry, School of Medicine, Firat University, Elazig 23200, Turkey
3Department of Immunology, School of Medicine, Firat University, Elazig 23200, Turkey
4Department of Microbiology, School of Medicine, Firat University, Elazig 23200, Turkey

Received 22 May 2006; Revised 23 August 2006; Accepted 23 August 2006

Copyright © 2006 Mehmet Yalniz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F H Luyckx, P J Lefebvre, and A J Scheen, “Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss,” Diabetes and Metabolism, vol. 26, no. 2, pp. 98–106, 2000. View at Google Scholar
  2. K Nakao, K Nakata, N Ohtsubo et al., “Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults,” American Journal of Gastroenterology, vol. 97, no. 7, pp. 1796–1801, 2002. View at Publisher · View at Google Scholar
  3. G Frühbeck, J Gómez-Ambrosi, F J Muruzábal, and M A Burrell, “The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation,” American Journal of Physiology—Endocrinology and Metabolism, vol. 280, no. 6, pp. E827–E847, 2001. View at Google Scholar
  4. B B Kahn and J S Flier, “Obesity and insulin resistance,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 473–481, 2000. View at Google Scholar
  5. J K Sethi and G S Hotamisligil, “The role of TNFα in adipocyte metabolism,” Seminars in Cell and Developmental Biology, vol. 10, no. 1, pp. 19–29, 1999. View at Publisher · View at Google Scholar
  6. D Holst and P A Grimaldi, “New factors in the regulation of adipose differentiation and metabolism,” Current Opinion in Lipidology, vol. 13, no. 3, pp. 241–245, 2002. View at Publisher · View at Google Scholar
  7. M W Rajala and P E Scherer, “Minireview: the adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis,” Endocrinology, vol. 144, no. 9, pp. 3765–3773, 2003. View at Publisher · View at Google Scholar
  8. U Pagotto, A Gambineri, V Vicennati, M L Heiman, M Tschöp, and R Pasquali, “Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 12, pp. 5625–5629, 2002. View at Publisher · View at Google Scholar
  9. J Crespo, A Cayón, P Fernández-Gil et al., “Gene expression of tumor necrosis factor a and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients,” Hepatology, vol. 34, no. 6, pp. 1158–1163, 2001. View at Publisher · View at Google Scholar
  10. S Chitturi, G Farrell, L Frost et al., “Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?” Hepatology, vol. 36, no. 2, pp. 403–409, 2002. View at Publisher · View at Google Scholar
  11. A Xu, Y Wang, H Keshaw, L Y Xu, K SL Lam, and G JS Cooper, “The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice,” Journal of Clinical Investigation, vol. 112, no. 1, pp. 91–100, 2003. View at Publisher · View at Google Scholar
  12. G Marchesini, U Pagotto, E Bugianesi et al., “Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance,” The Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5674–5679, 2003. View at Publisher · View at Google Scholar
  13. J M Hui, A Hodge, G C Farrell, J G Kench, A Kriketos, and J George, “Beyond insulin resistance in NASH: TNF-α or adiponectin?” Hepatology, vol. 40, no. 1, pp. 46–54, 2004. View at Publisher · View at Google Scholar
  14. G Musso, R Gambino, M Durazzo et al., “Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease,” Hepatology, vol. 42, no. 5, pp. 1175–1183, 2005. View at Publisher · View at Google Scholar
  15. E M Brunt, C G Janney, A M Di Bisceglie, B A Neuschwander-Tetri, and B R Bacon, “Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions,” American Journal of Gastroenterology, vol. 94, no. 9, pp. 2467–2474, 1999. View at Publisher · View at Google Scholar
  16. “Obesity: preventing and managing the global epidemic. Report of a WHO consultation,” World Health Organization Technical Report Series, vol. 894, pp. i-xii, 1–253, 2000.
  17. Y Yamamoto, H Hirose, I Saito, K Nishikai, and T Saruta, “Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 1, pp. 87–90, 2004. View at Publisher · View at Google Scholar
  18. Y Kamada, S Tamura, S Kiso et al., “Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin,” Gastroenterology, vol. 125, no. 6, pp. 1796–1807, 2003. View at Publisher · View at Google Scholar
  19. S Kaser, A Maschen, A Cayon et al., “Adiponectin and its receptors in non-alcoholic steatohepatitis,” Gut, vol. 54, no. 1, pp. 117–121, 2005. View at Publisher · View at Google Scholar